Welcome to the Life Sciences blog.

Here you will find articles and insights about life sciences and healthcare.

분류되지 않음
October 6, 2020

Digital innovation in drug development: Perspectives from pharma, tech and regulatory experts
Francesco Dellisanti
Director of Digital Health
Clarivate
분류되지 않음
September 1, 2020

Resilient supply chain requires geographic diversity
Mari Serebrov
Regulatory Editor, BioWorld
Clarivate
분류되지 않음
August 20, 2020

The future of continuous manufacturing in pharma
분류되지 않음
August 10, 2020

Patient enrollment continues to be a limiting factor for trial durations
Teresa Fishburne
Head of Centre for Medicines Research
Clarivate
분류되지 않음
August 6, 2020

Understanding disruptions to the antibiotic supply resulting from COVID-19
Nicole Reynolds
Solutions Consultant
Clarivate
분류되지 않음
July 13, 2020

Gaining insight with artificial intelligence
분류되지 않음
July 13, 2020

Organ-specific toxicity and personalized approaches
분류되지 않음
July 13, 2020

Identifying risks in drug discovery
분류되지 않음
July 1, 2020

Celebrating 30 years of BioWorld
Lynn Yoffee
News Director, BioWorld
Clarivate
분류되지 않음
June 19, 2020

2019 trends in regulatory approvals of new medicines
분류되지 않음
May 15, 2020

Applying regulatory flexibility in the age of COVID-19
Dr. Jenny Sharpe
Senior Scientific Writer, Centre for Innovation in Regulatory Science
Clarivate
분류되지 않음
April 7, 2020

The COVID-19 pandemic: European regulators respond
Monia Tumminello
Manager, Cortellis Regulatory Intelligence
Clarivate
분류되지 않음
April 7, 2020

Combating COVID-19: Insights from the BIO Europe conference
Asma Al-Shamahi
Deputy Managing Editor, Cortellis
Clarivate
분류되지 않음
March 31, 2020

Treating a pandemic: Drug repurposing, expanded access and emergency use authorization
Meg Egan-Auderset
Medical & Regulatory Writer, Cortellis
Clarivate
분류되지 않음
March 31, 2020

The trials must go on: Conducting clinical studies during the COVID-19 pandemic
Jaime Polychrones
Medical Writer, Cortellis Regulatory Intelligence
Clarivate